• Review • Previous Articles     Next Articles

Research advances on intra-arterial chemotherapy for the treatment of intraocular retinoblastoma

JIA Ruo-bing， JIA Ren-bing， FAN Xian-qun   

  1. Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011， China
  • Online:2016-09-28 Published:2016-10-31
  • Supported by:

    Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support, 20152223

PDF (PC)

979

Abstract:

Retinoblastoma (RB) is the most common intraocular malignant tumor in children. Chemotherapy remains the main method for the treatment of intraocular RB in term of saving affected eyes. Intra-arterial chemotherapy is a novel way to treat intraocular RB and can avoid systematic toxic side effects caused by intravenous chemotherapy. This article reviews the research advances on intra-arterial chemotherapy for the treatment of RB.

Key words: retinoblastoma, IIRC, intra-arterial chemotherapy (IAC)